Immunoregulatory network and cancer-associated genes: Molecular links and relevance to aging

Network Biology

Volumn 1, Issue 2, 2011, Pages 112-120

  Tacutu, Robi ^a   Budovsky, Arie ^a,b   Yanai, Hagai ^a   Wolfson, Marina ^a   Fraifeld, Vadim ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Judea Regional RandD Center   (Israel)

Author keywords

Aging; Cancer genes; Immunoregulators; Micro RNAs (miRNAs); PPI network; Protein protein interactions (PPI)

Indexed keywords

EID: 84995515754     PISSN: None     EISSN: 22208879     Source Type: Journal    
DOI: 10.0000/issn-2220-8879-networkbiology-2011-v1-0010     Document Type: Article

References (52)

1. Agarwal S, Busse PJ. 2010. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol, 104(3):183-90; quiz 190-2, 210
2. Ashburner M, Ball CA, Blake JA, et al. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genetics, 25(1): 25-29
3. Apte RN, Voronov E. 2008. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunological Review, 222: 222-241
4. Barabasi A, Oltvai ZN. 2004. Network biology: understanding the cell's functional organization. Nature Reviews Genetics, 5(2): 101-113
5. Blagosklonny MV. 2008. Prevention of cancer by inhibiting aging. Cancer Biology and Therapy, 7(10): 1520- 1524
6. Breitkreutz BJ, Stark C, Reguly T, et al. 2008. The BioGRID Interaction Database: 2008 update. Nucleic Acids Research, 36(Database issue): D637-D640
7. Budovsky A, Muradian KK, Fraifeld VE. 2006. From disease-oriented to aging/longevity-oriented studies. Rejuvenation Res, 9(2): 207-210
8. Budovsky A, Abramovich A, Cohen R, et al. 2007. Longevity network: construction and implications. Mechanisms of Ageing and Development, 128(1): 117-124
9. Budovsky A, Tacutu R, Yanai H, et al. 2009. Common gene signature of cancer and longevity. Mechanisms of Ageing and Development, 130(1-2): 33-39
10. Campisi J. 2011. Cellular senescence: putting the paradoxes in perspective. Current Opinion in Genetics and Development, 21(1): 107-112
11. Chung HY, Cesari M, Anton S, et al. 2009. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Research Reviews, 8(1): 18-30
12. Clayton T. 2010. Immunoregulators. Encyclopedia of Industrial Biotechnology: Bioprocess, Bioseparation, and Cell Technology. 1-25 (DOI 10.1002/9780470054581.eib609)
13. Coppé JP, Patil CK, Rodier F, et al. 2008. Senescence-associated secretory phenotypes reveal cellnonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol, 6(12): 2853-2868
14. Croci DO, Zacarías Fluck MF, Rico MJ, et al. 2007. Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother, 56(11): 1687-1700
15. Cutler RG, Mattson MP. 2006. The adversities of aging. Ageing Research Reviews, 5(3): 221-238
16. Davalos AR, Coppe JP, Campisi J, et al. 2010. Senescent cells as a source of inflammatory factors for tumor progression. Cancer and Metastasis Reviews, 29(2): 273-283
17. de Magalhães JP, Budovsky A, Lehmann G, et al. 2009. The Human Ageing Genomic Resources: online databases and tools for biogerontologists. Aging Cell, 8(1): 65-72
18. Dennis G Jr, Sherman BT, Hosack DA, et al. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biology, 4(5): P3
19. Derhovanessian E, Maier AB, Beck R, et al. 2010. Hallmark features of immunosenescence are absent in familial longevity. Journal of Immunology, 185(8): 4618-4624
20. Dixit VD. 2008. Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. Journal Leukocyte Biology, 84(4): 882-892
21. Dunn GP, Bruce AT, Ikeda H, et al. 2002. Cancer immunoediting: from immunosurveillance to tumor escape. Nature Immunology, 3(11): 991-998
22. Elkabets M, Ribeiro VS, Dinarello CA, et al. 2010. IL-1ß regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. European Journal of Immunology, 40(12): 3347- 3357
23. Fraifeld V, Kaplanski J, Kukulansky T, et al. 1995. Increased prostaglandin E2 production by concanavalin Astimulated splenocytes of old mice. Gerontology, 41(3): 129-133
24. Freund A, Orjalo AV, Desprez PY, et al. 2010. Inflammatory networks during cellular senescence: causes and consequences. Trends in Molecular Medicine, 16(5): 238-246
25. Fulop T, Larbi A, Witkowski JM, et al. 2010. Aging, frailty and age-related diseases. Biogerontology, 11(5): 547-563
26. Globerson A, Effros RB. 2000. Ageing of lymphocytes and lymphocytes in the aged. Immunology Today, 21(10): 515-521
27. Goodwin JS, Ceuppens J. 1983. Regulation of the immune response by prostaglandins. Journal of Clinical Immunology, 3(4): 295-315
28. Gregory CD, Pound JD. 2011. Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. Journal of Pathology, 223(2): 177-194
29. Gurtner GC, Werner S, Barrandon Y, et al. 2008. Wound repair and regeneration. Nature, 453(7193): 314-321
30. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4(1): 44-57
31. Ibrahim SS, Eldeeb MAR, Rady MAH, et al. 2011. The role of protein interaction domains in the human cancer network. Network Biology, 1(1): 59-71
32. Kanehisa M, Goto S, Furumichi M, et al. 2010. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research, 38(Database issue): D355-D360
33. Kim R, Emi M, Tanabe K. 2007. Cancer immunoediting from immune surveillance to immune escape. Immunology, 121(1): 1-14
34. Kozak W, Fraifeld V. 2004. Non-prostaglandin eicosanoids in fever and anapyrexia. Frontiers in Bioscience, 9: 3339-3355
35. Lu M, Zhang Q, Deng M, et al. 2008. An analysis of human microRNA and disease associations. PLoS One, 3(10): e3420
36. Papadopoulos GL, Reczko M, Simossis VA, et al. 2009. The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Research, 37(Database issue): D155-D158
37. Pawelec G, Derhovanessian E, Larbi A. 2010. Immunosenescence and cancer. Critical Reviews in Oncology and Hematology, 75(2): 165-172
38. Rodier F, Campisi J. 2011. Four faces of cellular senescence. Journal of Cell Biology, 192(4): 547-556
39. Schäfer M, Werner S. 2008. Cancer as an overhealing wound: an old hypothesis revisited. Nature Reviews Molecular Cell Biology, 9(8): 628-638
40. Schreiber RD, Old LJ, Smyth MJ. 2011. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science, 331(6024): 1565-1570
41. Shannon P, Markiel A, Ozier O, et al. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11): 2498-2504
42. Shurin MR, Shurin GV, Chatta GS. 2007. Aging and the dendritic cell system: implications for cancer. Critical Reviews in Oncology and Hematology, 64(2): 90-105
43. Spaulding CC, Walford RL, Effros RB. 1997. Calorie restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. Mechanisms of Ageing and Development, 93(1-3): 87- 94
44. Song X, Voronov E, Dvorkin T, et al. 2003. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. Journal of Immunology, 171(12): 6448-6456
45. Stark C, Breitkreutz BJ, Chatr-Aryamontri A, et al. 2011. The BioGRID Interaction Database: 2011 update. Nucleic Acids Research, 39(Database Issue): D698-D704
46. Tacutu R, Budovsky A, Fraifeld VE. 2010. The NetAge database: a compendium of networks for longevity, age-related diseases and associated processes. Biogerontology, 11(4): 513-522
47. Wang D, Dubois RN. 2010. Eicosanoids and cancer. Nature Reviews Cancer, 10(3): 181-193
48. Wang D, Qiu C, Zhang H, et al. 2010. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One, 5(9) pii: e13067
49. Wolfson M, Tacutu R, Budovsky A, et al. 2008. MicroRNAs: relevance to aging and age-related diseases. Open Longevity Science, 2: 66-75
50. Wolfson M, Budovsky A, Tacutu R, et al. 2009. The signaling hubs at the crossroad of longevity and agerelated disease networks. International Journal of Biochemistry and Cell Biology, 41(3): 516-520
51. Zhang WJ. 2011a. Network Biology: an exciting frontier science. Network Biology, 1(1): 79-80
52. Zhang WJ. 2011b. Constructing ecological interaction networks by correlation analysis: hints from community sampling. Network Biology, 1(2): 81-98